#LCSM Chat Topic 10/01/2020: Crazy year, crazy progress–#lungcancer at #ESMO20

Without a doubt, 2020 has been overwhelming for many reasons.  Perhaps lost among the bigger news cycles of #COVID19, the presidential race, and now the Supreme Court, has been the staggering progress that has been made in #LungCancer through the year.  There has been a remarkable run of FDA approvals, including drugs for non-small cell lung cancer (NSCLC) with RET rearrangements and MET exon 14 mutations, new first line therapies for NSCLC with EGFR mutations and ALK rearrangements, and new first line immunotherapy options for a variety of lung cancer scenarios.  This… Read More

#LCSM Chat Topic 9/3/2020: Is #Cancer Advocacy for Everyone?

The September 3 #LCSM Chat will tackle the issue of making time for cancer advocacy. Most media outlets shared that “Black Panther” star Chadwick Boseman died of colon cancer last week at age 43. He kept his illness a secret, and managed to complete several major film projects while dealing with surgeries and chemotherapy sessions.  While such a high-profile entertainer might have made a powerful colon cancer advocate, his choice to keep working as an actor has had (and continues to have) a positive impact on millions of lives internationally. It’s hard… Read More

#LCSM Chat Topic 8/6/2020: Update on #COVID19 and #LungCancer

#LCSM Chat last discussed COVID-19 and lung cancer in its April 2nd Chat. Much has changed in a mere four months. The USA has had about 4.5 million COVID-19 cases and over 150,000 deaths to date. We have a better understanding of some things related to COVID-19, yet we know more is unknown. The public’s patience with lockdowns and preventative measures wears thin. With each passing day, our necessary human social interactions become more distant, which is harmful to all in the lung cancer community. The strain on some hospitals and clinics… Read More